Across its top 20 institutional holders, CLVT's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 25/100, avg. turnover score 34/100).

Quarterly Activity

Recent Activity

+$587.4M

Total Buy Value

$496.0M

Total Sell Value

New buy77

Trim33

Add110

Sold out41

187

Net Buyers

Net Sellers

Smart Money Convergence

CLVT does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CLVT

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-06

2026-07-06

Clarivate Plc has signed an agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for $600 million. The deal includes $500 million in cash at closing, $25 million in deferred payments, and a $75 million unsecured senior note. The sale is expected to close by the end of 2026, and it does not require shareholder approval.

View Full Filing (SEC EDGAR)

2026-07-06

No AI summary for this filing type

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

G21810109, 129603106, g21810109

FAQ

Who are the top institutional investors holding Clarivate Plc (CLVT)?

Major stakeholders currently include Leonard Green & Partners, L.P. ($295.2M), Exor N.V. ($170.3M), Clarkston Capital Partners, LLC ($108.4M). Based on the latest 13F filings, there are a total of 254 tracked investment funds and institutions maintaining positions in CLVT.

What is the overall institutional sentiment toward CLVT recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $213.7M, driven by 187 managers accumulating shares while 74 reduced their exposure.

Which institutions have been selling or reducing their CLVT positions?

In the latest period, 33 funds trimmed their holdings, and 41 managers completely exited their positions. The aggregate reported sell value was $496.0M.

Are there any notable investors adding CLVT to their portfolios?

Yes, buying activity remains notable. 77 institutions opened new positions in {ticker}, and 110 existing holders added to their shares. The total reported buy value for the quarter amounted to $587.4M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access CLVT's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/CLVT

CLI

npx alphasmo stocks get CLVT

Full API & MCP documentation →